5AM Venture Management, LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
5AM Venture Management, LLC disclosed 31 US equity positions worth $419.1m in its Q4 2024 13F filing. The largest position was TRDA at 18.2% of the reported book, followed by ELVN and SKYE. Against the Q3 2024 filing, it opened 4 new positions, added to 0 and reduced 6 among the top 31 holdings.
What did 5AM Venture Management, LLC own in Q4 2024? Top 31 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TRDA ENTRADA THERAPEUTICS INC | 18.2% | $76.2m | 4,408,379 | 0% | held | |
| 2 | ELVN ENLIVEN THERAPEUTICS INC | Healthcare | 8.8% | $36.7m | 1,629,765 | -7% | reduced |
| 3 | SKYE SKYE BIOSCIENCE INC | 6.7% | $28.1m | 9,913,168 | 0% | held | |
| 4 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 6.6% | $27.5m | 596,660 | -8% | reduced |
| 5 | ARTV ARTIVA BIOTHERAPEUTICS INC | 5.7% | $23.7m | 2,353,304 | 0% | held | |
| 6 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 5.3% | $22.4m | 1,027,711 | -17% | reduced |
| 7 | BHVN BIOHAVEN LTD | Healthcare | 4.3% | $17.9m | 478,972 | 0% | held |
| 8 | PHVS PHARVARIS N V | 3.6% | $15.3m | 797,600 | 0% | held | |
| 9 | MLTX MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | 3.6% | $15.3m | 282,313 | 0% | held |
| 10 | CAMP CAMP4 THERAPEUTICS CORP | 3.6% | $15.3m | 2,927,915 | – | new | |
| 11 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 3.4% | $14.1m | 736,595 | 0% | held |
| 12 | CNTA CENTESSA PHARMACEUTICALS PLC | 3.3% | $13.9m | 830,945 | -35% | reduced | |
| 13 | ERAS ERASCA INC | Healthcare | 3.2% | $13.6m | 5,405,404 | 0% | held |
| 14 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.1% | $13.1m | 170,000 | -50% | reduced |
| 15 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.1% | $13.1m | 939,298 | 0% | held |
| 16 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 3.0% | $12.6m | 497,270 | 0% | held |
| 17 | EYPT EYEPOINT PHARMACEUTICALS INC | Healthcare | 1.9% | $7.8m | 1,050,000 | 0% | held |
| 18 | VKTX VIKING THERAPEUTICS INC | Healthcare | 1.8% | $7.6m | 189,593 | -20% | reduced |
| 19 | VOR VOR BIOPHARMA INC | 1.7% | $7.1m | 6,361,723 | 0% | held | |
| 20 | ANAB ANAPTYSBIO INC | Healthcare | 1.1% | $4.7m | 357,733 | 0% | held |
| 21 | AKERO THERAPEUTICS INC | 1.1% | $4.6m | 165,000 | – | new | |
| 22 | SCPH SCPHARMACEUTICALS INC | 1.0% | $4.3m | 1,200,647 | 0% | held | |
| 23 | TARA PROTARA THERAPEUTICS INC | 1.0% | $4.2m | 800,000 | – | new | |
| 24 | GHRS GH RESEARCH PLC | 1.0% | $4.0m | 572,665 | 0% | held | |
| 25 | RLYB RALLYBIO CORP | 0.8% | $3.5m | 3,630,724 | 0% | held | |
| 26 | SLN SILENCE THERAPEUTICS PLC | 0.8% | $3.3m | 476,200 | 0% | held | |
| 27 | AVU0 ADVERUM BIOTECHNOLOGIES INC | 0.6% | $2.5m | 541,666 | 0% | held | |
| 28 | ALEC ALECTOR INC | Healthcare | 0.4% | $1.9m | 995,841 | – | new |
| 29 | MERSANA THERAPEUTICS INC | 0.4% | $1.9m | 1,305,000 | 0% | held | |
| 30 | CDTX CIDARA THERAPEUTICS INC | 0.4% | $1.5m | 56,725 | 0% | held | |
| 31 | ZNTL ZENTALIS PHARMACEUTICALS INC | Healthcare | 0.4% | $1.5m | 490,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.